Trial Profile
A Multicenter Phase II Trial of Docetaxel Combined With Cisplatin (CDDP) as a Neo-Adjuvant Chemotherapy in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2009
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 19 Jun 2009 New trial record